GSK
GlaxoSmithKline PLC ADR
GlaxoSmithKline PLC ADR 13F Holders
GSK Stock Ownership Activity
- # of activities:
- 3
- AVG reported price*:
- $62.48
- Current price*:
- -19.77%($50.13)
3 value investing gurus have made changes to the GlaxoSmithKline PLC ADR (GSK) position according to the gurus' 2013 Q2 SEC quarterly report(s). GSK has been bought (as a new position) by 3 guru(s)
Which gurus or hedge funds bought GSK in 2013 Q2?
According to the 2013 Q2 SEC filing(s) GlaxoSmithKline PLC ADR (GSK) has been bought by 3 gurus / funds: Warren Buffett - Berkshire Hathaway (new buy), Tweedy, Browne Co All Funds (US) (new buy) and Lewis Sanders - Sanders Capital (new buy).
To see more about who is investing in GlaxoSmithKline PLC ADR (GSK), please go to the GSK ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".